Onkure Therapeutics Inc Revenue per Employee (OKUR), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Onkure Therapeutics Inc   (NASDAQ: OKUR)
 

Onkure Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Onkure Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 24,000, below the company average number of $79,800.
Within the Healthcare sector Employees of 489 other companies have achieved higher revenue per employee. While Onkure Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 2058 to 3409. Onkure Therapeutics Inc has 45 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OKUR Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change - - -57.4 % -63.69 % -
Sales per Employee (TTM) $ 24,000 41,822 62,578 76,289 100,533
OKUR's Total Ranking # 3409 # 2058 # 1886 # 1360 #
Seq. Revenue Change - - -26.37 % -22.44 % -14.13 %

OKUR Company Profile >> Back to OKUR Efficiency Comparisons >> Compare OKUR Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 174
Healthcare Sector # 490
Overall Market # 3409

Revenue per Employee Statistics
High Average Low
$ 100,533 $ 79,800 $ 62,578
(Sep 30 2025)   (Mar 31 2026)



Financial Statements
Onkure Therapeutics Inc 's Revenue MRQ $ 0 Millions Visit OKUR's Income Statement
Onkure Therapeutics Inc 's Revenues TTM $ 1 Millions Visit OKUR's aggregate revenue growth
What are OKUR's Sales? Visit OKUR's Sales by Segment




Other Ratios
Onkure Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
OKUR's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for OKUR's Competitors
Revenue per Employee for OKUR's Suppliers
Revenue per Employee for OKUR's Customers

You may also want to know
OKUR's Sales Growth Rates OKUR's Pe Price to earnings ratio OKUR's Receivables Turnover Ratio OKUR's Stock Quote
OKUR's Net Income Growth Rates OKUR's Ps Price to Sales ratio OKUR's Sales per Employee OKUR's Asset Turnover Ratio
OKUR's Net Margin OKUR's Pb Price to Book ratio OKUR's Financial Strength Ratios OKUR's Dividend Payout Ratio
Date modified: 2026-11-05T09:53:54+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Dbv Technologies S a   22,611.76 $ 3.844  Million 170 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.